The Latest: New cases in India below 60,000 for 5th day

NEW DELHI — India has reported below 60,000 new coronavirus cases for a fifth day as the promise of a free COVID-19 vaccine turned into a key state election issue. The Health Ministr...

Trump, Biden fight over the raging virus, climate and race

U.S. President Donald Trump and Democratic challenger Joe Biden fought over how to tame the raging coronavirus in Thursday’s (Oct. 22) final 2020 debate, largely shelving the rancor that oversha...

Trump, Biden go after each other on coronavirus

In their final debate, President Donald Trump and Democratic Joe Biden offered sharply different visions of how to handle the surging pandemic, with the incumbent declaring that the virus will go away...

Academia Sinica predicts Taiwanese COVID-19 vaccine unavailable before mid-2021

TAIPEI (Taiwan News) — Academia Sinica President James Liao (廖俊智) on Wednesday (Oct. 22) predicted that a coronavirus vaccine developed by Taiwanese researchers will not be available until at le...

Asian stocks follow Wall Street lower on lack of US aid plan

BEIJING (AP) — Asian stocks followed Wall Street lower on Thursday as investors watched Washington for signs of whether political leaders can agree on an economic aid plan in the two weeks before the ...

Slovenia struggles to contain surge in COVID-19 cases

Skofja Loka is a small town with almost 12,000 inhabitants to the northwest of the capital, Ljubljana. According to official statistics, 348 people in the municipality have been infected with COVID-19...

The Latest: India issues virus warning ahead of state polls

NEW DELHI — Indian authorities are worried elections in the third-largest state and a religious congregation could spread the coronavirus. India added fewer than 60,000 new cases fo...

Has coronavirus already peaked in India?

The COVID-19 cases in India had peaked in mid-September and the active cases can largely be contained by February if preventive guidelines are followed, a government-appointed panel of scientists said...

Regulators, experts take up thorny vaccine study issues

WASHINGTON (AP) — The U.S. regulators who will decide the fate of COVID-19 vaccines are taking an unusual step: Asking outside scientists if their standards are high enough. The Food...

Next up in hunt for COVID-19 vaccine: Testing shots in kids

The global hunt for a COVID-19 vaccine for kids is only just beginning — a lagging start that has some U.S. pediatricians worried they may not know if any shots work for young children in time for the...

Brazil's Bolsonaro rejects Chinese vaccine against COVID-19

SAO PAULO (AP) — Brazilian President Jair Bolsonaro overruled his own health minister on Wednesday, rejecting the announced purchase of 46 million doses of CoronaVac, a potential vaccine against COVID...

U.S. trial of AstraZeneca COVID-19 vaccine may resume this week - sources

AstraZeneca Plc's AZN.L COVID-19 vaccine trial in the United States is expected to resume as early as this week after the U.S. Food and Drug Administration completed its review of a serious illnes...

Tokyo Olympics try to get word out about COVID-19 measures

TOKYO (AP) — Tokyo Olympic officials want the world to know they are working on measures to combat the COVID-19 pandemic at next year's games, even if they don't know exactly what they will be. ...

Many thorny global situations hinge on US election outcome

Four years after Donald Trump's election reframed how many nations interacted with the United States, the way that the world’s foremost superpower moves forward after its presidential electi...

Asia Today: Philippines allowing foreign travel to resume

MANILA, Philippines (AP) — The Philippines on Wednesday lifted a ban on non-essential foreign trips by Filipinos, but the immigration bureau said the move did not immediately spark large numbers of de...